MRNA

Moderna, Inc. $143.97 1M +126.1% 3M +190.0% YTD +366.5% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.4%
Next 1 week
+1.1%
Next 1 month
-0.0%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 79
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.45%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.90 +0.4% · Seasonal tilt (7y) -0.4%
$55.4B market cap (#541 US) $5.2B/day volume 192% volatility +492% 1-year -71% from ATH
52-week range · 79% of the way up · -18% from the high
$22.28$176.66

Congressional trades in MRNA Full tracker →

6 members · 7 buys / 18 sells · $214K–$735K disclosed · latest filing Sep 9, 2026.

BUY MS Maria Elvira Salazar · traded Aug 19, 2026 $1K–$15K
SELL MS Maria Elvira Salazar · traded Aug 19, 2026 $1K–$15K
SELL RB Rob Bresnahan · traded Apr 8, 2025 $1K–$15K
BUY RB Rob Bresnahan · traded Feb 25, 2025 $1K–$15K
SELL JJ Julie Johnson · traded Jan 15, 2025 $1K–$15K
SELL JG Josh Gottheimer · traded Feb 1, 2024 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2023 $1K–$15K
SELL DG Daniel Goldman · traded Jul 12, 2023 $50K–$100K

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 53 days) · EPS est. -1.29.

1-day std dev
9.3%
Finished up
55%
Biggest pop
+22.7%
Biggest drop
-21.0%

Standard deviation of the close-to-close move over the last 31 reports. History, not a forecast.

Short interest — low Full report →

Crowding 18/100
Squeeze risk 39/100
12.0% of float short 1.0 days to cover shorts -26% last read 61th %ile of its history as of 2026-08-31

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.